Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Operating Leases (2022 - 2025)

Historic Operating Leases for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $1.1 million.

  • Orchestra BioMed Holdings' Operating Leases fell 2134.44% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 2134.44%. This contributed to the annual value of $1.7 million for FY2024, which is 6252.41% up from last year.
  • Orchestra BioMed Holdings' Operating Leases amounted to $1.1 million in Q3 2025, which was down 2134.44% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Operating Leases registered a high of $1.7 million during Q4 2024, and its lowest value of $1.0 million during Q4 2023.
  • Its 4-year average for Operating Leases is $1.3 million, with a median of $1.3 million in 2023.
  • Per our database at Business Quant, Orchestra BioMed Holdings' Operating Leases plummeted by 3832.44% in 2023 and then soared by 6252.41% in 2024.
  • Quarter analysis of 4 years shows Orchestra BioMed Holdings' Operating Leases stood at $1.7 million in 2022, then crashed by 38.32% to $1.0 million in 2023, then soared by 62.52% to $1.7 million in 2024, then tumbled by 32.72% to $1.1 million in 2025.
  • Its Operating Leases stands at $1.1 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.5 million for Q1 2025.